Evidence map›Paper›PMID 38276496›Full record

ArticlePharmaceutics2023

Paola Zanetta, Chiara Ballacchino, Diletta Francesca Squarzanti, Angela Amoruso, Marco Pane, Barbara Azzimonti

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. The Role of ProbioticsInternational journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Antibiotics (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Paola ZanettaLaboratory of Applied Microbiology, Department of Health Sciences (DISS), Center for Translational Research on Allergic and Autoimmune Diseases (CAAD), School of Medicine, Università del Piemonte Orientale (UPO), Corso Trieste 15/A, 28100 Novara, Italy.ORCID 0000-0001-8547-3090
Chiara BallacchinoLaboratory of Applied Microbiology, Department of Health Sciences (DISS), Center for Translational Research on Allergic and Autoimmune Diseases (CAAD), School of Medicine, Università del Piemonte Orientale (UPO), Corso Trieste 15/A, 28100 Novara, Italy.ORCID 0000-0001-7440-2369
Diletta Francesca SquarzantiLaboratory of Applied Microbiology, Department of Health Sciences (DISS), Center for Translational Research on Allergic and Autoimmune Diseases (CAAD), School of Medicine, Università del Piemonte Orientale (UPO), Corso Trieste 15/A, 28100 Novara, Italy.ORCID 0000-0001-8090-7718
Angela AmorusoProbiotical Research S.r.l., Via Mattei 3, 28100 Novara, Italy.ORCID 0000-0001-5919-2658
Marco PaneProbiotical Research S.r.l., Via Mattei 3, 28100 Novara, Italy.ORCID 0000-0003-3575-6919
Barbara AzzimontiLaboratory of Applied Microbiology, Department of Health Sciences (DISS), Center for Translational Research on Allergic and Autoimmune Diseases (CAAD), School of Medicine, Università del Piemonte Orientale (UPO), Corso Trieste 15/A, 28100 Novara, Italy.ORCID 0000-0001-6364-6595
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITProbiotical (Italy) · IT

Funding

Universitá del Piemonte Orientale FAR-2017
6 · The paper itself

Abstract

Methicillin-resistant biofilm-forming

Indexed as

cell viabilityLactobacillus johnsoniimulti-drug resistanceprobiotic cell-free supernatantskin cancerskin infectionskin inflammationStaphylococcus aureusvitamin Dwound healing

Identifiers

PMID38276496
PMCPMC10820395
OpenAlexW4390058511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.